marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-18-2024
ADiTx Therapeutics Income Statement 2011-2024 | ADTX
Annual Income Statement ADiTx Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
735 K | 42.7 K | 141 K | 25.7 M | - | - | - | - | - | - | - | - | - |
Shares |
302 K | 46.4 K | 382 K | 6.9 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
2.43 | 0.92 | 0.368 | 3.03 | - | - | - | - | - | - | - | - | - |
Net Income |
-32.4 M | -27.6 M | -46.4 M | -9.15 M | -5.83 M | -5.69 M | - | - | - | - | - | - | - |
Revenue |
645 K | 934 K | 105 K | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
757 K | 767 K | 78 K | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
-112 K | 167 K | 27.1 K | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-26.1 M | -25.5 M | -41.9 M | -8.87 M | -5.87 M | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | 5.84 K | - | - | - | - | - | - | - | - | - |
EBITDA |
-25.6 M | -25.1 M | -41.6 M | -8.85 M | -5.87 M | -5.61 M | - | - | - | - | - | - | - |
Operating Expenses |
26 M | 25.6 M | 42 M | 8.87 M | 5.87 M | 5.61 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
1.84 M | 16 M | 587 K | 7.85 M | 5.69 M | 5.04 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement ADiTx Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
116 K | 1.8 M | 1.61 M | 33 K | 5.08 K | 154 K | 114 K | 108 K | 35.8 K | 911 K | 892 K | 889 K | 348 K | 14.6 M | 13.8 M | 13 M | 7.44 M | 3.93 M | 3.91 M | 3.82 M | 3.87 M | 3.84 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-12.8 M | -7.55 M | -14.7 M | - | -9.91 M | -5.68 M | -5.98 M | - | -7.56 M | -5.85 M | -6.06 M | - | -9.76 M | -6.18 M | -6.38 M | - | -2.74 M | -534 K | -1.19 M | - | -1.08 M | -2.56 M | -1.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
6.85 K | 44.3 K | 79.7 K | - | 124 K | 221 K | 218 K | - | 323 K | 215 K | 210 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
468 K | 23.1 K | 65.8 K | - | 107 K | 186 K | 178 K | - | 234 K | 175 K | 188 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
-461 K | 21.1 K | 13.9 K | - | 17.6 K | 35.2 K | 40.1 K | - | 89.4 K | 39.9 K | 22.2 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-4.7 M | -5.98 M | -11.5 M | - | -8.1 M | -4.23 M | -5.78 M | - | -5.39 M | -5.77 M | -6.12 M | - | -6.07 M | -5.78 M | -6.09 M | - | -2.74 M | -398 K | -1.06 M | - | -1.08 M | -2.56 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | 740 K | 70.8 K | - | - | 15.8 K | - | - | - | 5.84 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-4.55 M | -5.82 M | -11.4 M | - | -7.99 M | -4.12 M | -5.67 M | - | -5.29 M | -5.67 M | -6.02 M | - | -5.81 M | -5.67 M | -6.03 M | - | -2.74 M | -398 K | -1.06 M | - | -1.08 M | -2.56 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
4.24 M | 6 M | 11.5 M | - | 8.11 M | 4.27 M | 5.82 M | - | 5.48 M | 5.81 M | 6.14 M | - | 6.07 M | 5.78 M | 6.09 M | - | 2.74 M | 398 K | 1.06 M | - | 1.08 M | 2.56 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
3.72 M | 4.42 M | 3.36 M | - | 7.17 M | 3.67 M | 4.37 M | - | 3.92 M | 3.79 M | 134 K | - | 557 K | 4.8 M | 5.1 M | - | 2.45 M | 367 K | 856 K | - | 1.06 M | 2.51 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency